Law360 (March 12, 2020, 11:05 PM EDT) — A California federal jury sided with the U.S. Securities and Exchange Commission in its suit accusing a hemp company and its executives of pocketing $4 million in proceeds from the unregistered sale of more than 33 million shares of the company’s stock, the SEC announced Thursday.
On Wednesday, the jury found Curative Biosciences Inc. liable on all counts, including violations of the Securities Act of 1933 and the Securities Exchange Act of 1934, according to an announcement from the SEC. The company’s chairwoman, Katherine West Alverson, and her husband, former board Chairman William M. Alverson, aided and abetted in the company’s violations…
Recent Comments